| Global Antiviral Drugs Market Report, History and Forecast 2015-2026, Breakdown Data by Manufacturers, Key Regions, Types and Application ntiviral drugs are medicines that decrease the ability of flu viruses to reproduce. when used as directed, antiviral drugs may help reduce the duration of flu. Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt and will significantly affect the Antiviral Drugs market in 2020.The new crown epidemic will raise market awareness in the field of antiviral drugs.
- P: g7 K8 h2 p) W In February 2020, Failover was used in China for experimental treatment of COVID-19. Due to the continuation of COVID-19, the use of related antiviral drugs such as Interferon Alfa, lopinavir, ribavirin, and ribavirin will be greatly increased. This report mainly analyses the impact of Coronavirus COVID-19 on the Antiviral Drugs industry. Figure 1. COVID-19 Virus Structure and Electron Micrograph 
Source: Secondary Sources, Expert Interviews and QYResearch, 2020 Based on our recent survey, we have several different scenarios about the Antiviral Drugs YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ 56 billion in 2019. The market size of Antiviral Drugs will reach US$ xx in 2026, with a CAGR of xx% from 2020 to 2026. [url=]Figure 2. Global Antiviral Drugs Market Size (Value), (US$ Billion), 2015 VS 2019[/url] 
Source: Secondary Sources, Expert Interviews and QYResearch, 2020 The report has also analyzed the competitive landscape of the market with some of the key players include Novartis, Roche, Bristol Myers Squibb, GlaxoSmithKline, Johnson & Johnson, Merck, AbbVie, Gilead Sciences, CHITAI TIANQING, Cosunter Pharmaceutical and Qingfeng Pharmaceutical, etc. Base on drug types, Influenza Drugs is primarily segmented into Nucleos(t)ide Analogues, Direct-acting Antiviral Dgents (DAAs) and Interferon Alfa, etc. Table 1. Major Global Antiviral Drug Categories in 2018 : P" A" M8 Q' o( K" k$ nItem Drugs Indications Company 2017 Sales (US $ Billion) 2018 Sales (US $ Billion) Growth Rate (%)
& V: ]7 U/ M) E( O( K1 Genvoya HIV Gilead 3.67 4.62 25.9% ; Y* ?* J2 ~0 }* c; |
2 Triumeq HIV GSK 3.2 3.51 9.7%
8 x5 i8 o5 S. m6 @. `) j" jrs238848.rs.hosteurope.de3 Mavyret HCV AbbVie / 3.44 / ( k. P% j4 \# \: @" C+ R
4 Truvada HIV Gilead 3.13 2.99 -4.5% 人在德国 社区; V, p$ U" ~( m5 D6 L" t$ ?( f
5 Tivicay HIV GSK 1.83 2.18 19.1% 2 t+ f. U1 K9 s3 K; x5 E# b
6 Epclusa HCV Gilead 3.51 1.97 -43.9% 8 a9 ]. h% y; O6 G7 u; a1 ~/ g" F
7 Prezista HIV Johnson & Johnson 1.82 1.96 7.7%
6 E( o8 A) Q- k6 ~2 N7 m/ }5 R8 Odefsey HIV Gilead 1.11 1.59 43.2%
0 Z+ g! M; [9 b% ^( h$ S" Vrs238848.rs.hosteurope.de9 Descovy HIV Gilead 1.21 1.58 30.6% 1 B' e; F& w, J" |7 N; O! t
10 Harvoni HCV Gilead 4.37 1.22 -72.1%
5 n: g# s; y1 B2 x0 h人在德国 社区11 Atripla HIV Gilead 1.8 1.21 -32.8%
; F; i; O1 @" o) l12 Biktarvy HIV Gilead / 1.18 / 3 X0 N1 m/ w. k+ E# O6 q
13 Isentress HIV MSD 1.2 1.14 -5.0%
5 ~; @. K7 p a/ S! e8 Q3 b0 y人在德国 社区14 Baralude HIV & HBV BMS 1.05 0.74 -29.5%
$ Y3 G0 m3 T8 ~1 x* T" X0 ^15 Complera/Eviplera HIV Gilead 0.97 0.65 -33.0%
8 D( W7 h9 T' P4 I. d$ b O' R" i9 GSource: Secondary Sources, Expert Interviews and QYResearch, 2020 Antiviral drugs are mainly used for the treatment of common viral diseases in humans, mainly including the following categories: Hepatitis, HIV / AIDS, Herpes, Influenza and Others. Figure 3. Global Antiviral Drugs Market share by treatment in 2019 
B5 ?6 m( d& C- W/ H4 K c/ i7 i( c. `, LSource: Secondary Sources, Expert Interviews and QYResearch, 2020 In 2019, the major application of antiviral drugs are Hepatitis and HIV/AIDS Therapeutics, accounted about more than 73% in the market. Before 2016, the global antiviral drug market maintained rapid growth in the field of hepatitis C. After 2016, the growth rate has slowed down. Since 2018, HIV drugs have become the main category to maintain the overall market growth of antiviral drugs. The rapid growth of antiviral drugs is partly due to the increasing trend of influenza virus epidemics in recent years, and partly due to the increased use of antiviral drugs. Figure 4. New Cases of Hepatitis C in China (2004-2019) 
Source: Secondary Sources, Expert Interviews and QYResearch, 2020 Antiviral drugs in China are mainly hepatitis B indications. Among them, entecavir is the main treatment drug. However, due to price cuts and other policies, tenofovir, propofol and tenofovir have continued to increase. In this market study, analysts have estimated the reverse transcriptase inhibitors to dominate the antiviral drugs market during the forecast period. These are compounds that are used to inhibit the reverse transcriptase enzyme. The capability of this enzyme to catalyze the process of conversion of viral RNA into DNA, to infect the healthy host cell and replicate it is the key contributor to the growth of this segment in the hiv treatment drugs market. The research report studies the Antiviral Drugs market using different methodologies and analyzes to provide accurate and in-depth information about the market. For a clearer understanding, it is divided into several parts to cover different aspects of the market. Each area is then elaborated to help the reader comprehend the growth potential of each region and its contribution to the global market. The researchers have used primary and secondary methodologies to collate the information in the report. They have also used the same data to generate the current market scenario. This report is aimed at guiding people towards an apprehensive, better, and clearer knowledge of the market. Global Antiviral Drugs market: Drivers and Restraints This section covers the various factors driving the global Antiviral Drugs market. To understand the growth of the market it is important to analyze the various drivers present the market. It provides data by revenue and volume of different regions and their respective manufacturers. This data will elaborate on the market share occupied by them, predict their revenue concerning strategies, and how they will grow in the future. After explaining the drivers, the report further evaluates the new opportunities and current trends in the market. Market restraints are factors hampering market growth. Studying these factors is equally pivotal as they help a reader need understand the weaknesses of the market. Global Antiviral Drugs market: Segment Analysis The global Antiviral Drugs market is split into two segments, type, and application. The product type briefs on the various types of products available in the market. The report also provides data for each product type by revenue and sales for the forecast time period. It covers the price of each type of product. The other segment on the report, application, explains the various uses of the product and end-users. In the report, the researchers have also provided sales according to the consumption of the product. Global Antiviral Drugs market: Regional Analysis The major regions covered in the report are North America, Europe, Asia-Pacific, South America, Middle East & Africa, etc. The report has specifically covered major countries including U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc. It includes revenue and volume analysis of each region and their respective countries for the forecast years. It also contains country-wise volume and revenue from the year 2015 to 2020. Additionally, it provides the reader with accurate data on volume sales according to the consumption for the same years. Global Antiviral Drugs market: Key Players The report lists the major manufacturers in the regions and their respective market share on the basis of global revenue. It also explains their strategic moves in the past few years, investments in product innovation, and changes in leadership to stay ahead in the competition. This will give the reader an edge over others as a well-informed decision can be made looking at the holistic picture of the market. By the product type, the market is primarily split into Reverse Transcriptase Inhibitors Protease Inhibitors Fusion Inhibitors Immune System Modulators By the end users/application, this report covers the following segments Hepatitis Therapeutics HIV/AIDS Therapeutics Herpes Therapeutics Influenza Therapeutics Competitive Landscape: The report provides a list of all the key players in the Antiviral Drugs market along with a detailed analysis of the strategies, which the companies are adopting. The strategies mainly include new product development, research, and development, and also provides revenue shares, company overview, and recent company developments to remain competitive in the market. The Antiviral Drugs key manufacturers in this market include: Roche Johnson & Johnson Merck Novartis Bristol-Myers Squibb Gilead Sciences GlaxoSmithKline AbbVie " q2 g0 s- \2 t2 n: E% l5 n
for more information please go https://www.qyresearch.com/index ... iviral-drugs-market and you can go https://www.qyresearch.comto know more and more if you need any help you can contact qifeifei@qyresearch.com / telephone number ：18910840196 00861082945717 " \* F' c! ?: u
QY Research support best market reports for you. | 
发表于 2020-4-7 09:21
| 